Psychosomatic Medicine for Anxiety

Functional somatic syndromes with a depression and the anxiety are of moderate magnitude but were highly significant statistically as when compared with a healthy persons and which controls with medical disorders of known organic pathology. So it is very important to evaluate the medical causes where anxiety is accompanied by the disproportionate physical symptoms as like Tachycardia or atypical physical symptom like confusion. The main psychosomatic therapy which is knows as Cognitive behavioural therapy (CBT) should be concerned as a first-line treatment for the situational anxiety and also the anxiety disorders. The use of Benzodiazepines which can help to improve primary anxiety in a short term and Tricyclic Antidepressants like Mirtazapine were also considered. Selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors were also used in the psychosomatic therapies.

 

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  • Benzodiazepines
  • Tricyclic Antidepressants

Related Conference of Psychosomatic Medicine for Anxiety

October 19-20, 2017

25th World Summit on Psychology, Psychiatry & Psychotherapy

San Francisco, California, USA
November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia
December 07-08, 2017

29th World Psychiatrists Meet

Dubai, UAE
May 21-22, 2018 [10 Plenary Forums- 1 Happiness Event]

29th World Summit on Positive Psychology, Mindfulness and Psychotherapy

New York City, New York, USA

Psychosomatic Medicine for Anxiety Conference Speakers

Recommended Sessions

Related Journals

Are you interested in